ArticleClinical parkinsonism & related disorders2025
Regional changes in the prevalence of Parkinson's disease over a ten-year period in the state of Texas.
Article in Clinical parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary prevention of Parkinson's disease: proceedings, the 8C's and a position statement from the Parkinson's disease prevention think tank.NPJ Parkinson's disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Region specific epidemiological knowledge is needed to better help government and private entities plan and develop interventions to address accelerating diagnoses of Parkinson's disease (PD). We measured the within-state prevalence patterns of PD within the state of Texas, United States, over a ten-year period to include factors of sex and race/ethnicity, with a specific focus on county and regional patterns. Methods: Publicly available data from the State of Texas Outpatient Public Use Data File (PUDF) evaluated for the years 2012 and 2022. Individuals with a PD specific diagnosis code were included. Age group, race, ethnicity, sex, and county of residence were used to calculate state and county case counts for the years 2012 and 2022. Spatial cluster analysis was applied to assess concentrations of diagnoses across Texas. Results: Prevalence rates of PD increased substantially in Texas from 2012 to 2022, especially among those aged 65 and older and Hispanics. Males had a higher prevalence rate in both years, though both sexes doubled their prevalence over the ten-year period. Spatial cluster analysis showed changes in diagnosis concentration, from the central and northeastern regions to the southwestern border region. Conclusion: Outpatient diagnoses of PD increased substantially from 2012 to 2022. Spatial distribution of PD risk evolved over the decade; such that risk for PD was greatest in the southwestern region of Texas in 2022 compared to all other areas. Prevalence trends in Texas mirror global trends for PD and should inform prevention and intervention strategies in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.